101 related articles for article (PubMed ID: 1121805)
1. [Changes of the indicators of hemostasis during corticosteroid treatment of systemic lupus erythematosus].
Iakumova NIa; Ivanova AV; Sukhanov AA
Vopr Revm; 1975; (1):63-5. PubMed ID: 1121805
[No Abstract] [Full Text] [Related]
2. [Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus].
Rass IT; Borisov IA; Nikishova TA; Sura VV
Ter Arkh; 1977; 49(8):110-5. PubMed ID: 929380
[No Abstract] [Full Text] [Related]
3. [Systemic erythematosus--the blood].
Yamaguchi H
Nihon Rinsho; 1968 Dec; 26(12):3426-9. PubMed ID: 5753024
[No Abstract] [Full Text] [Related]
4. Intraplatelet and urinary serotonin concentrations in systemic lupus erythematosus with reference to its clinical manifestations.
Kanai H; Tsuchida A; Yano S; Naruse T
J Med; 1989; 20(5-6):371-90. PubMed ID: 2534129
[TBL] [Abstract][Full Text] [Related]
5. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Gonda N; Sumiya M; Kano S
Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
[TBL] [Abstract][Full Text] [Related]
6. [The thrombocyte link in blood-coagulation homeostasis in patients with systemic lupus erythematosus].
Vas'kova NG
Vrach Delo; 1990 Nov; (11):51-3. PubMed ID: 2098984
[TBL] [Abstract][Full Text] [Related]
7. [Change in the amino acid spectrum of the blood serum in patients with lupus erythematosus under the effect of therapy].
Pavlova LT
Vestn Dermatol Venerol; 1970 Jul; 44(7):11-4. PubMed ID: 5511088
[No Abstract] [Full Text] [Related]
8. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
[TBL] [Abstract][Full Text] [Related]
9. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
Harnett M; Kodali BS
Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
[No Abstract] [Full Text] [Related]
10. Clinical and laboratory observations in eight patients with lupus-type circulating anticoagulant.
Canciani MT; Maspero ML; Cattaneo M; Mannucci PM
Haematologica; 1979 Jun; 64(3):309-21. PubMed ID: 113299
[No Abstract] [Full Text] [Related]
11. [Presocyl in the treatment of lupus erythematosus].
Glavinskaia TA; Zernov VP; Ostroumova TN
Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
[No Abstract] [Full Text] [Related]
12. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
13. Experience of a platelet factor 3 immunoinjury technique in the detection of antiplatelet antibody in systemic lupus erythematosus and other clinical disorders.
Kutti J; Safai-Kutti S
Scand J Rheumatol; 1978; 7(1):17-20. PubMed ID: 353972
[TBL] [Abstract][Full Text] [Related]
14. [Discontinuous corticosteroid treatment of systemic lupus erythematosus].
Tareeva IE
Klin Med (Mosk); 1972 Jun; 50(6):95-9. PubMed ID: 5086287
[No Abstract] [Full Text] [Related]
15. [Plasma coagulation and fibrinolysis in systemic lupus erythematosus (author's transl)].
Arnalich Fernández F; Gil Aguado A; Enríquez L; Navarro JL; Barbado Hernández FJ; Vázquez Rodríguez JJ
Med Clin (Barc); 1979 Jun; 73(1):5-10. PubMed ID: 470505
[No Abstract] [Full Text] [Related]
16. [Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
Itoh H; Fujihira T; Harada S; Kido M; Kajiki A; Nakashima Y; Kuroiwa A
Kekkaku; 1984 Apr; 59(4):303-8. PubMed ID: 6748459
[No Abstract] [Full Text] [Related]
17. [Objective evaluation of remote results of treatment of systemic lupus erythematosus].
Ivanova MM; Nasonova VA; Folomeeva OM; Speranskiĭ AI; Kozlova VN
Ter Arkh; 1977; 49(9):60-6. PubMed ID: 929421
[No Abstract] [Full Text] [Related]
18. [Prednisolone sensitivity of peripheral blood mononuclear cells of patients with systemic lupus erythematosus clinically resistant to glucocorticoids and the effects of carbon hemoperfusion].
Petrova GN; Baranova FS; Popova LK; Dmitriev AA
Ter Arkh; 1987; 59(8):107-10. PubMed ID: 3686432
[TBL] [Abstract][Full Text] [Related]
19. [Anticoagulants with antithrombinase activity in systemic lupus erythematosus (author's transl)].
Jungers P; Dougados M; Ganzegel C; Kremp O; Jacques C; Noel LH; Josso F
Nephrologie; 1980; 1(2):67-8. PubMed ID: 7301023
[TBL] [Abstract][Full Text] [Related]
20. Thrombokinetics in systemic lupus erythematosus A preliminary report.
Bergström AL; Kutti J; Safai-Kutti S
Pahlavi Med J; 1976 Apr; 7(2):180-94. PubMed ID: 1272594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
